During the past decade, Ankara University Biotechnology Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ankara University Biotechnology Institute" #1 collaborator was "International Olympic Committee" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ankara University Biotechnology Institute" are "Retinitis Pigmentosa" (3 trials), "Acute Macular Neuroretinopathy" (1 trials), "Central Serous Chorioretinopathy" (1 trials), "Chronic Central Serous Chorioretinopathy" (1 trials) and "Cystoid Macular Edema" (1 trials). Many other conditions were trialed in "Ankara University Biotechnology Institute" in a lesser frequency.

Most popular intervention types in "Ankara University Biotechnology Institute" are "Biological" (4 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Platelet rich plasma" (2 trials), "Electromagnetic stimulation" (1 trials), "Repetitive electromagnetic stimulation" (1 trials), "SL-MPL treatment protocol was performed with a 577 nm yellow laser (EasyRet, Quantel Medical, Cedex, France)" (1 trials) and "Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ankara University Biotechnology Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ankara University Biotechnology Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ankara University Biotechnology Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ankara University Biotechnology Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".